A Tiered Management System of Osteoporosis in China

NCT ID: NCT03916289

Last Updated: 2019-04-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

15000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-01

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is a management gap in China. This study aims to establish a tiered management system of osteoporosis for Chinese patients. Including:

1. Developing a national hierarchical health management network platform for middle-aged and elderly osteoporosis patients. With this platform, the data of medical records, laboratory results would be shared between medical institutions. And primary hospitals can refer the patients to the nearest medical centre for advanced auxiliary examinations and diagnosis.
2. Establishing a muti-level hospital collaboration, doctor-patient interaction management model of osteoporosis.
3. To explore and establish a early warning and screening pathways for osteoporosis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoporosis Osteopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention would be taken

No intervention would be taken. Patients enrolled would be managed by this tiered diagnosis and treatment system and receive standard treatment according to clinical guidelines of osteoporosis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Postmenopausal women or men aged 50 years or older

Conform to the diagnosis of osteoporosis or osteopenia as followings:

1. Bone mineral density measured by dual-energy X-ray absorptiometry show a T-score ≤ -1.0 at neck of femur or total hip or lumber 1-4 OR
2. Have at least once major osteoporotic fracture
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking Union Medical College Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

The propotion of patients treated in comliance with guidelines Xia, MD

Role: STUDY_CHAIR

Peking Union Medical College Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing Friendship Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing Jishuitan Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing shijingshan hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Peking University Third Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Fujian Provincial Hospital

Fuzhou, Fujian, China

Site Status RECRUITING

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China

Site Status RECRUITING

The third hospital of hebei medical university

Shijiazhuang, Hebei, China

Site Status RECRUITING

The Second Hospital of Xiangya,Central South University

Changsha, Hunan, China

Site Status RECRUITING

Nanjing Drum Tower Hospital

Nanjing, Jiangsu, China

Site Status RECRUITING

The Second Affiliated Hospital of Soochow University

Suzhou, Jiangsu, China

Site Status RECRUITING

Jiangxi Provincial People's Hospital

Nanchang, Jiangxi, China

Site Status RECRUITING

The fourth hospital of jilin university

Changchun, Jilin, China

Site Status RECRUITING

Shengjing hospital affiliated to China medical university

Shenyang, Liaoning, China

Site Status RECRUITING

People's hospital of ningxia hui autonomous region

Yinchuan, Ninxia, China

Site Status RECRUITING

The Sixth People's Hospital Affiliated to Shanghai Jiaotong University

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Huadong hospital affiliated to fudan university

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Shanghai first people's hospital affiliated to Shanghai jiaotong university

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Tongji hospital affiliated to tongji university

Shanghai, Shanghai Municipality, China

Site Status RECRUITING

Xi'an Red Cross hospital

Xi'an, Shannxi, China

Site Status RECRUITING

The first affiliated hospital of shanxi medical university

Taiyuan, Shanxi, China

Site Status RECRUITING

West China hospital of sichuan university

Chengdu, Sichuan, China

Site Status RECRUITING

Western theater general hospital

Chengdu, Sichuan, China

Site Status RECRUITING

Tianjin hospital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Weibo Xia, MD

Role: CONTACT

+86 69151552

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Weibo Xia, MD

Role: primary

Hai Tang

Role: primary

Liang He

Role: primary

Hongyu Dong

Role: primary

Yu Pei

Role: primary

Chunli Song

Role: primary

Jianming Hou

Role: primary

Wen Wu

Role: primary

Yukun Li

Role: primary

Zhongjian Xie

Role: primary

Hua Lin

Role: primary

Youjia Xu

Role: primary

Yanan Huo

Role: primary

Mengmeng Zhang

Role: primary

Qin Fu

Role: primary

Jinhan Lv

Role: primary

Zhenlin Zhang

Role: primary

Qun Cheng

Role: primary

Li You

Role: primary

Keqin Zhang

Role: primary

Yuhong Zeng

Role: primary

Jin Dong

Role: primary

Decai Chen

Role: primary

Xiaolan Jin

Role: primary

Aijun Chao

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JS-1894

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.